US approves first drug for rare erection disorder

Associated Press

9:08 am | Saturday, December 7th, 2013

WASHINGTON — The Food and Drug Administration has approved the first drug to treat an unusual condition that causes painful, curved erections in men.

The agency says it approved the biotech drug Xiaflex to treat Peyronie’s disease, which causes an abnormal bend in the penis during erection. The disease is caused by scar tissue and can lead to pain and other difficulties during sex.

The FDA says the injectable drug is the first non-surgical treatment for the disease.

Drugmaker Auxilium Pharmaceuticals estimates 5 percent of U.S. men are affected.

The FDA said it is limiting distribution of the drug to certified physicians and health care centers due to serious potential side effects, including injury of the penis. Health care professionals must enroll and complete a training program before prescribing the drug.

RELATED STORIES:

Hardness more important than size or frequency

More sex, please – we’re avoiding erectile dysfunction

Follow Us

Recent Stories:

Complete stories on our Digital Edition newsstand for tablets, netbooks and mobile phones; 14-issue free trial. About to step out? Get breaking alerts on your mobile.phone. Text ON INQ BREAKING to 4467, for Globe, Smart and Sun subscribers in the Philippines.

Short URL: http://business.inquirer.net/?p=155501

Tags: Erectile Dysfunction , Erection Disorder , Erections , Health Science , Peyronie’s disease , Sex , Xiaflex

Factual errors? Contact the Philippine Daily Inquirer's day desk. Believe this article violates journalistic ethics? Contact the Inquirer's Reader's Advocate. Or write The Readers' Advocate:

c/o Philippine Daily Inquirer Chino Roces Avenue corner Yague and Mascardo Streets, Makati City, Metro Manila, Philippines Or fax nos. +63 2 8974793 to 94

seo tools